z-logo
Premium
Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed
Author(s) -
DávilaSeijo P.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19434
Subject(s) - psoriasis , medicine , clinical trial , intensive care medicine , medline , dermatology , political science , law
Linked Article:   Afach et al. Br J Dermatol 2021; 184 :415–424.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here